Grown Rogue International (GRUSF) Return on Capital Employed (2018 - 2026)

Grown Rogue International (GRUSF) recorded quarterly Return on Capital Employed of 1658104.72% in Q1 2026, up 49923048.69% quarter-over-quarter from 3.32% in Q4 2025.

Grown Rogue International (GRUSF) Return on Capital Employed (2018 - 2026) Analysis & Trends

Grown Rogue International's Return on Capital Employed history runs 7 years deep, the most recent figure standing at 1658104.72% for Q1 2026.

  • In Q1 2026, Return on Capital Employed changed N/A year-over-year to 1658104.72%; the TTM figure through Mar 2026 stood at 1658104.72% (changed N/A YoY), while the FY2025 annual figure was 2.09%, up 167.0% from the prior year.
  • Return on Capital Employed was 1658104.72% for Q1 2026 at Grown Rogue International, up from 3.32% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 1658104.72% in Q1 2026 to a low of 3.32% in Q4 2025.
  • Historically, Return on Capital Employed has averaged 331635.81% across 3 years, with a median of 18.2% in 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 8.52%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 27.58%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 21.43%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 20.04%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 7.34%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 6.92%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -1.92%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 14.85%
10 Grown Rogue International - - 3.96 Mn 1,658,104.72%

Historic Data

Download Data
DateValue
Mar 31, 2026 1,658,104.72%
Dec 31, 2025 3.32%
Sep 30, 2024 15.70%
Jun 30, 2024 18.20%
Mar 31, 2024 37.11%
Apr 30, 2021 -44.09%
Jan 31, 2021 -8,362.97%
Oct 31, 2020 -35.71%
Jul 31, 2020 -943.90%
Jan 31, 2020 1,469.05%
Jan 31, 2019 -186.75%
Oct 31, 2018 616.00%